-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
-
Summary
-
Kairos Pharma, LTD. quarterly Liabilities, Current history and growth rate from Q4 2023 to Q3 2025.
- Kairos Pharma, LTD. Liabilities, Current for the quarter ending September 30, 2025 was $402K, a 76% decline year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)